News - fasiglifam, Takeda Pharmaceuticals

Filter

Popular Filters

Is the diabetes market facing a blockbuster-free future?

23-05-2013

Japanese drug major Takeda's (TYO: 4502) recently announced positive late-stage results for new type…

DiabetesfasiglifamMarkets & MarketingPharmaceuticalResearchTakeda Pharmaceuticals

Back to top